Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor explains options for patients.

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

Forget “Ozempic face”, the colloquial term for ... However, common side effects and impacts can have knock-on effects “and must be considered”, she continues. Sharma also acknowledges ...

The Therapeutic Goods Administration has received complaints of blindness and vision loss in one eye among users of Ozempic and Wegovy ... be aware of whether side effects may be temporary ...